Latest data from May 6, 2022
Number of Health Center respondents = 60 (83% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 | 5,477 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) | 85.34% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 | 210 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) | 77.78% |
Patients by Race and Ethnicity
| Race/Ethnicity | Patients Tested, Virus Detection (PCR, Antigen)2 | Patients Tested Positive, Virus Detection (PCR, Antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 13.13% | 20.00% |
| White, Hispanic/Latino Patients | 60.25% | 56.19% |
| Black/African American, Non-Hispanic/Latino Patients | 6.45% | 7.62% |
| Black/African American, Hispanic/Latino Patients | 0.62% | 0.00% |
| Asian Patients3 | 1.21% | 0.95% |
| American Indian/Alaska Native Patients3 | 0.38% | 0.00% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.26% | 0.48% |
| Patients with More Than One Race3 | 2.10% | 0.95% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 5.19% | 3.81% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 1.39% | 0.48% |
| Unreported/Refused to Report Race and Ethnicity | 9.04% | 9.52% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 661 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 90.43% |
| COVID-19 Immunization Series Completed | 661 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 91.97% |
| COVID-19 Immunization Series Additional | 1,613 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 87.52% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 9.08% | 7.41% | 12.09% |
| White, Hispanic/Latino Patients | 67.17% | 64.75% | 64.41% |
| Black/African American, Non-Hispanic/Latino Patients | 7.72% | 7.72% | 7.07% |
| Black/African American, Hispanic/Latino Patients | 1.51% | 0.76% | 0.56% |
| Asian Patients3 | 1.36% | 1.66% | 1.49% |
| American Indian/Alaska Native Patients3 | 0.45% | 0.15% | 2.67% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.00% | 0.15% | 0.19% |
| Patients with More Than One Race3 | 1.51% | 0.91% | 0.37% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 6.05% | 8.77% | 8.00% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 1.82% | 1.21% | 0.74% |
| Unreported/Refused to Report Race and Ethnicity | 3.33% | 6.51% | 2.42% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 35.00% |
| 1 to 24 Hours | 35.00% |
| More Than 24 Hours | 28.33% |
| N/A | 1.67% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
| Metrics | Value |
|---|---|
| Financial reimbursement for costs associated with vaccine administration | 10.00% |
| Staffing to administer the vaccine | 18.33% |
| Vaccine confidence | 25.00% |
| Vaccine storage capacity | 5.00% |
| Vaccine supply | 1.67% |
| Other | 11.67% |
| None | 45.00% |
Operations and Staff
| Metrics | Value |
|---|---|
| COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program | 33.33% |
| Average Percent of Health Center Visits Conducted Virtually | 12.00% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 26.67% |
| Number of Mobile Van Sites | 7 |
| Number of Pop-up Clinics | 3 |
| Number of School-Based Vaccination Sites | 5 |
| Number of Family Vaccination Clinics | 36 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Direct provision of monoclonal antibody therapies | 1.67% |
| Refer patients to another organization that provides monoclonal antibody therapies | 60.00% |
| None | 38.33% |
Challenges in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Access to therapeutics | 13.33% |
| Patient awareness/education | 3.33% |
| Staffing capacity | 21.67% |
| Therapy administration/onsite logistics | 18.33% |
| Other | 5.00% |
| None | 61.67% |
Test Kit Distribution
| Metrics | Value |
|---|---|
| Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program | 33 |
| Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program | 54,682 |
Test Kit Distribution Methods4
| Metrics | Value |
|---|---|
| Provided to Existing Health Center Patients | 75.76% |
| Provided to General Public Who Came to the Health Center | 51.52% |
| Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 24.24% |
| Provided at Other Community Events | 27.27% |
| Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 9.09% |
| Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 24.24% |
| Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 15.15% |
| Provided to school-age children and/or their families directly or through partnerships with schools | 18.18% |
| Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 18.18% |
| Other | 3.03% |
N95 Mask Distribution
| Metrics | Value |
|---|---|
| Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask Program | 19 |
| Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program | 29,819 |
N95 Mask Distribution Methods5
| Metrics | Value |
|---|---|
| Provided to Existing Health Center Patients | 89.47% |
| Provided to General Public Who Came to the Health Center | 42.11% |
| Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 26.32% |
| Provided at Other Community Events | 26.32% |
| Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 15.79% |
| Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 31.58% |
| Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 31.58% |
| Provided to school-age children and/or their families directly or through partnerships with schools | 21.05% |
| Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 26.32% |
| Other | 5.26% |
Oral Antiviral Medication Distribution
| Metrics | Value |
|---|---|
| Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program | 8 |
| Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication | 95.12% |
Oral Antiviral Medication Distribution by Race and Ethnicity
| Race/Ethnicity | Value |
|---|---|
| White, Non-Hispanic/Latino Patients | 0.00% |
| White, Hispanic/Latino Patients | 82.93% |
| Black/African American, Non-Hispanic/Latino Patients | 0.00% |
| Black/African American, Hispanic/Latino Patients | 0.00% |
| Asian Patients3 | 0.00% |
| American Indian/Alaska Native Patients3 | 2.44% |
| Native Hawaiian/Other Pacific Islander Patients3 | 2.44% |
| Patients with More Than One Race3 | 0.00% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 7.32% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 0.00% |
| Unreported/Refused to Report Race and Ethnicity | 4.88% |
Oral Antiviral Medication Distribution by Population Type
| Metrics | Value |
|---|---|
| Migratory/Agricultural Workers | 0.00% |
| Patients Experiencing Homelessness | 0.00% |
| Patients Who Are Residents of Public Housing | 4.88% |
| Patients with Limited English Proficiency | 17.07% |
| Children Under 18 Years of Age | 2.44% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.
5 Percentages are calculated using the number of health centers that have distributed N95 masks received through the HRSA Health Center COVID-19 N95 Mask Program as the denominator.
Date Last Reviewed: